Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal

BSE1726.4533.6 (+1.98 %)

PREV CLOSE ( ) 1692.85

OPEN PRICE ( ) 1677.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 17911

TODAY'S LOW / HIGH ( )1671.90 1737.90

52 WK LOW / HIGH ( )1272 1803.6

NSE1725.1032.3 (+1.91 %)

PREV CLOSE( ) 1692.80

OPEN PRICE ( ) 1692.00

BID PRICE (QTY) 1725.10 (1437)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 334674

TODAY'S LOW / HIGH( ) 1672.50 1738.00

52 WK LOW / HIGH ( )1272.6 1803

Quarters

Select year

( in Million)

Particulars

Mar 2026

Dec 2025

Sep 2025

Jun 2025

Audited / UnAudited

UnAudited

Net Sales

7027

6598

7306

6698

Total Expenditure

5159

4805

5065

4775

PBIDT (Excl OI)

1868

1793

2241

1923

Other Income

240

244

248

281

Operating Profit

2108

2037

2489

2204

Interest

Exceptional Items

-301

PBDT

2047

1664

2441

2157

Depreciation

446

421

405

346

Profit Before Tax

1601

1243

2036

1811

Tax

279

329

514

471

Provisions and contingencies

Profit After Tax

1322

914

1522

1340

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

1322

914

1522

1340

Minority Interest

-9

-16

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

1313

905

1506

1324

Equity Capital

1676

838

Face Value (IN RS)

Reserves

Calculated EPS

7.83

5.39

17.97

15.79

Calculated EPS (Annualised)

31.33

21.59

71.88

63.19

No of Public Share Holdings

78392750

78388750

39194375

38714375

% of Public Share Holdings

46.79

46.21

PBIDTM% (Excl OI)

26.58

27.17

30.67

28.71

PBIDTM%

29.99

30.87

34.06

32.90

PBDTM%

29.13

25.21

33.41

32.20

PBTM%

22.78

18.83

27.86

27.03

PATM%

18.81

13.85

20.83

20.00

Notes

Risk Disclosures on Derivatives

Quarterly Results

DR. LAL PATHLABS LTD.